Position in CELU
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,003
-$5,020 QoQ
Shares Held
1,680
-62.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 39 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in CELU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. CELU ranks #513 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in CELU
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,003 | 1,680 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,023 | 4,529 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,709 | 3,343 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,514 | 1,215 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,381 | 1,215 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,101 | 1,215 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,527 | 1,215 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,868 | 6,017 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,802 | 1,215 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,364 | 1,217 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,005 | 12,173 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,787 | 12,562 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $8,747 | 16,413 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $20,345 | 32,815 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $18,978 | 14,712 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $15,962 | 6,910 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $35,019 | 10,300 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $32,314 | 3,710 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $34,636 | 6,765 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,517 | 2,898 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 GXGX | — | 865 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 GXGX | — | 3,315 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 GXGX | — | 1,038 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 GXGX | — | 96 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 GXGX | — | 106 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 GXGX | — | 136 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||